Document Detail


The role of lipoic acid in prevention of nitroglycerin tolerance.
MedLine Citation:
PMID:  18616939     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Besides other organic nitrates, nitroglycerin (glyceryl trinitrate; GTN) has been used to treat acute heart failure particularly due to ischemic heart disease. However, one of serious clinical problems of the GTN therapy, particularly a long-standing medication, is hemodynamic tolerance to GTN, manifested by the decreased therapeutic efficacy of the drug. The most recent studies have suggested that mitochondrial lipoate/dihydrolipoate system-dependent aldehyde dehydrogenase-2 plays a key role in nitric oxide release from GTN. The aldehyde dehydrogenase-2 performs three enzymatic activities of dehydrogenase, esterase and reductase. The reductase activity is responsible for bioactivation of organic nitrates, such as GTN yielding nitrite and dinitrate (1,2-GDN/1,3-GDN, approximately 8:1). In view of a large contribution of dihydrolipoic acid to stabilization and regeneration of thiol groups, necessary for the reductase activity of aldehyde dehydrogenase-2, we conducted studies aimed to determine whether lipoic acid administration to rats is able to prevent GTN tolerance. The studies were conducted on 4 groups of animals: control saline-treated, model GTN-tolerant, GTN + lipoic acid-treated, lipoic acid alone-administered groups. On the 9th day of experiment animals were given i.v. therapeutic dose of GTN. We measured in all animals systolic and diastolic blood pressure before injection of therapeutic dose of GTN into the cadual vein and during 20 min thereafter. Levels of nitric oxide and reactive oxygen species and activities of glutathione peroxidase and superoxide dismutase were assayed in the aorta, plasma and heart of all animals. In addition, levels of malondialdehyde, and non-protein thiols, and activities of glutathione S-transferase and gamma-glutamyl transpeptidase were evaluated in the heart and plasma. The obtained results indicate that treatment of rats with a combination of lipoic acid and GTN can efficiently counteract GTN tolerance.
Authors:
Magdalena Dudek; Marek Bednarski; Anna Bilska; Małgorzata Iciek; Maria Sokołowska-Jezewicz; Barbara Filipek; Lidia Włodek
Related Documents :
6778399 - Drug interference on some biochemical parameters of rat cerebral cortex during post-isc...
9877329 - Inhibition of the synthesis of eicosanoid-like substances in a human oral cancer cell l...
7134819 - Accumulation of pyroglutamic acid (5-oxoproline) in homocystinuria.
21475879 - The bone anabolic carotenoids p-hydroxycinnamic acid and β-cryptoxanthin antagonize nf...
21543199 - Towards a whole-body systems [multi-organ] lipidomics in alzheimer's disease.
458819 - S-2,omega-diaminoalkyl dihydrogen phosphorothioates as antiradiation agents.
7748169 - Morphogens in vertebrate development: how do they work?
9748409 - Characterization of bradykinin-related peptides generated in the plasma of six sarcopte...
12527179 - A new stressed test to predict the foreign matter formation of minodronic acid in solut...
Publication Detail:
Type:  Journal Article     Date:  2008-06-27
Journal Detail:
Title:  European journal of pharmacology     Volume:  591     ISSN:  0014-2999     ISO Abbreviation:  Eur. J. Pharmacol.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-12     Completed Date:  2008-10-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  1254354     Medline TA:  Eur J Pharmacol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  203-10     Citation Subset:  IM    
Affiliation:
Laboratory of Pharmacological Screening, Jagiellonian University, Collegium Medicum, 9, Medyczna Street, PL 30-688 Kraków, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antioxidants / pharmacology*
Aorta / drug effects,  metabolism
Blood Pressure / drug effects
Drug Tolerance
Glutathione Peroxidase / drug effects,  metabolism
Heart / drug effects
Injections, Intravenous
Male
Nitric Oxide / metabolism
Nitroglycerin / administration & dosage,  pharmacology*
Rats
Rats, Wistar
Reactive Oxygen Species / metabolism
Superoxide Dismutase / drug effects,  metabolism
Thioctic Acid / pharmacology*
Time Factors
Vasodilator Agents / administration & dosage,  pharmacology*
Chemical
Reg. No./Substance:
0/Antioxidants; 0/Reactive Oxygen Species; 0/Vasodilator Agents; 10102-43-9/Nitric Oxide; 55-63-0/Nitroglycerin; 62-46-4/Thioctic Acid; EC 1.11.1.9/Glutathione Peroxidase; EC 1.15.1.1/Superoxide Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evaluation of Polo-like Kinase 1 inhibition on the G2/M checkpoint in Acute Myelocytic Leukaemia.
Next Document:  Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2...